Millie Gottwald is a seasoned professional in clinical development with over two decades of experience in leading roles within the biopharmaceutical sector. Currently serving as Sr Director of Clinical Development at 89bio since October 2021, Millie has previously held senior positions at NGM Biopharmaceuticals, Jazz Pharmaceuticals, Tobira Therapeutics, Gilead Sciences, Alexza Pharmaceuticals, Sunesis Pharmaceuticals, and Scios Inc. Millie's academic background includes a Pharm.D and Neurology Fellowship from the University of California, San Francisco, and a B.S. in Biochemistry from San Francisco State University. Additionally, Millie contributed as an Assistant Clinical Professor in a volunteer capacity at the University of California-SF from 2002 to 2022.
This person is not in the org chart
This person is not in any offices